Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway

References

• Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy[J]. Nat Rev Cardiol. 2018;15(7):387–407.
   PubMed Web of Science ®Google Scholar
• Wu J, Dai F, Li C, et al. Gender differences in cardiac hypertrophy[J]. J Cardiovasc Transl Res. 2020;13(1):73–84.
   PubMed Web of Science ®Google Scholar
• Kimura K, Kanazawa H, Ieda M, et al. Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure[J]. Auton Neurosci. 2010;156(1–2):27–35.
   PubMed Web of Science ®Google Scholar
• Ferreira JP, Rossignol P, Zannad F. Renin-angiotensin-aldosterone system and kidney interactions in heart failure[J]. Journal of the renin-angiotensin-aldosterone system. 2019;20(4):1604354041
   Web of Science ®Google Scholar
• Li S, Zhang L, Guo Y, et al. Relationship of cardiac sympathetic nerve innervation and excitability to cardiac hypertrophy in very elderly male hypertensive patients[J]. High Blood Press Cardiovasc Prev. 2013;20(3):115–121.
   PubMedGoogle Scholar
• Oka T, Akazawa H, Naito AT, et al. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure[J]. Circ Res. 2014;114(3):565–571.
   PubMed Web of Science ®Google Scholar
• Gallo S, Vitacolonna A, Bonzano A, et al. ERK: a key player in the pathophysiology of cardiac hypertrophy[J]. Int J Mol Sci. 2019;20(9):9.
   Web of Science ®Google Scholar
• Bernardo BC, Weeks KL, Pretorius L, et al. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies[J]. Pharmacol Ther. 2010;128(1):191–227.
   PubMed Web of Science ®Google Scholar
• Liao HH, Zhang N, Meng YY, et al. Myricetin alleviates pathological cardiac hypertrophy via TRAF6/TAK1/MAPK and Nrf2 signaling pathway[J]. Oxid Med Cell Longev. 2019;2019:6304058.
   PubMed Web of Science ®Google Scholar
• Chen D, Li Z, Bao P, et al. Nrf2 deficiency aggravates angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation[J]. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1253–1264.
   PubMed Web of Science ®Google Scholar
• Galie M, Covi V, Tabaracci G, et al. The role of Nrf2 in the antioxidant cellular response to medical ozone exposure[J]. Int J Mol Sci. 2019;20(16):16.
   Web of Science ®Google Scholar
• Xiao X, Lu Z, Lin V, et al. MicroRNA miR-24-3p reduces apoptosis and regulates Keap1-Nrf2 pathway in mouse cardiomyocytes responding to ischemia/reperfusion injury[J]. Oxid Med Cell Longev. 2018;2018:7042105.
   PubMed Web of Science ®Google Scholar
• Velusamy P, Mohan T, Ravi DB, et al. Targeting the Nrf2/ARE signalling pathway to mitigate isoproterenol-induced cardiac hypertrophy: plausible role of hesperetin in redox homeostasis[J]. Oxid Med Cell Longev. 2020;2020:9568278.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang HB, Yang J, et al. Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR[J]. Eur Rev Med Pharmacol Sci. 2018;22(21):7500–7508.
   PubMed Web of Science ®Google Scholar
• Zhang N, An X, Lang P, et al. Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro[J]. Biomed Pharmacother. 2019;109:1016–1023.
   PubMed Web of Science ®Google Scholar
• Tang J, Raza A, Chen J, et al. A systematic review on the sinomenine derivatives[J]. Mini Rev Med Chem. 2018;18(11):906–917.
   PubMed Web of Science ®Google Scholar
• Jiang W, Fan W, Gao T, et al. Analgesic mechanism of sinomenine against chronic pain[J]. Pain Res Manag. 2020;2020:1876862.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang W, Zheng B, et al. Sinomenine attenuates traumatic spinal cord injury by suppressing oxidative stress and inflammation via Nrf2 pathway[J]. Neurochem Res. 2019;44(4):763–775.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zou B, Tan Y, et al. Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling[J]. Pharmacol Res. 2019;142:140–150.
   PubMed Web of Science ®Google Scholar
• Lee JY, Yoon SY, Won J, et al. Sinomenine produces peripheral analgesic effects via inhibition of voltage-gated sodium currents[J]. Neuroscience. 2017;358:28–36.
   PubMed Web of Science ®Google Scholar
• Yoo JH, Ha TW, Hong JT, et al. Sinomenine, an alkaloid derived from sinomenium acutum potentiates pentobarbital-induced sleep behaviors and Non-Rapid Eye Movement (NREM) Sleep in rodents[J]. Biomol Ther (Seoul). 2017;25(6):586–592.
   PubMed Web of Science ®Google Scholar
• Yang H, Jiang C, Chen X, et al. Protective effects of sinomenine against LPS-induced inflammation in piglets[J]. Microb Pathog. 2017;110:573–577.
   PubMed Web of Science ®Google Scholar
• Fu YF, Li L, Fang P, et al. Sinomenine’s protective role and mechanism in stress load‐induced heart failure[J]. J Pharm Pharmacol. 2020;72(2):209–217.
   PubMed Web of Science ®Google Scholar
• Li L, Fang P, Chen J, et al. Protective effect of sinomenine on isoproterenol-induced cardiac hypertrophy in mice[J]. Journal of applied biomedicine. 2021;19(3):142–148.
   PubMed Web of Science ®Google Scholar
• Safeukui I, Buffet PA, Perrot S, et al. Surface area loss and increased sphericity account for the splenic entrapment of subpopulations of Plasmodium falciparum ring-infected erythrocytes[J]. PloS One. 2013;8(3):e60150.
   PubMed Web of Science ®Google Scholar
• Gao C, Chen H, Niu C, et al. Protective effect of Schizandrin B against damage of UVB irradiated skin cells depend on inhibition of inflammatory pathways[J]. Bioengineered. 2017;8(1):36–44.
   PubMed Web of Science ®Google Scholar
• Jung S, Shin J, Oh J, et al. Cytotoxic and apoptotic potential of phyllodium elegans extracts on human cancer cell lines[J]. Bioengineered. 2019;10(1):501–512.
   PubMed Web of Science ®Google Scholar
• Jiang L, Yang F, Zhao Q, et al. MicroRNA-665 mediates propofol-induced cell apoptosis in human stem cell-derived neurons[J]. Bioengineered. 2019;10(1):493–500.
   PubMed Web of Science ®Google Scholar
• Yao J, Gao R, Luo M, et al. Possible role of microRNA miRNA-IL-25 interaction in mice with ulcerative colitis[J]. Bioengineered. 2020;11(1):862–871.
   PubMed Web of Science ®Google Scholar
• Taylor SC, Posch A. The design of a quantitative western blot experiment[J]. Biomed Res Int. 2014;2014:361590–361598.
   PubMed Web of Science ®Google Scholar
• Dludla PV, Essop MF, Gabuza KB, et al. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels[J]. Heart Vessels. 2017;32(8):1025–1031.
   PubMed Web of Science ®Google Scholar
• Li X, Tong J, Liu J, et al. Down-regulation of ROCK2 alleviates ethanol-induced cerebral nerve injury partly by the suppression of the NF-κB signaling pathway[J]. Bioengineered. 2020;11(1):779–790.
   PubMed Web of Science ®Google Scholar
• Zeng O, Li F, Li Y, et al. Effect of novel gasotransmitter hydrogen sulfide on renal fibrosis and connexins expression in diabetic rats[J]. Bioengineered. 2016;7(5):314–320.
   PubMed Web of Science ®Google Scholar
• D’Ascenzi F, Pelliccia A, Corrado D, et al. Right ventricular remodelling induced by exercise training in competitive athletes[J]. Eur Heart J Cardiovasc Imaging. 2016;17(3):301–307.
   PubMed Web of Science ®Google Scholar
• Lu F, Xing J, Zhang X, et al. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol[J]. Mol Cell Biochem. 2013;381(1–2):41–50.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Ravassa S, Beaumont J, et al. New targets to treat the structural remodeling of the myocardium[J]. J Am Coll Cardiol. 2011;58(18):1833–1843.
   PubMed Web of Science ®Google Scholar
• Gao Z, Lin Y, Zhang P, et al. Sinomenine ameliorates intervertebral disc degeneration via inhibition of apoptosis and autophagy in vitro and in vivo[J]. Am J Transl Res. 2019;11(9):5956–5966.
   PubMed Web of Science ®Google Scholar
• Fu C, Wang Q, Zhai X, et al. Sinomenine reduces neuronal cell apoptosis in mice after traumatic brain injury via its effect on mitochondrial pathway[J]. Drug Des Devel Ther. 2018;12:77–84.
   PubMed Web of Science ®Google Scholar
• Liu F, Li N, Long B, et al. Cardiac hypertrophy is negatively regulated by miR-541[J]. Cell Death Dis. 2014;5(4):e1171.
   PubMedGoogle Scholar
• Li X, Lan Y, Wang Y, et al. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway[J]. Mol Med Rep. 2017;15(5):2574–2582.
   PubMed Web of Science ®Google Scholar
• Gao W, Guo N, Zhao S, et al. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling[J]. Cell Stress Chaperones. 2020;25(6):899–908.
   PubMed Web of Science ®Google Scholar
• Guo Z, Lu J, Li J, et al. JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing beta-MHC expression[J]. Mol Cell Endocrinol. 2018;477:1–14.
   PubMed Web of Science ®Google Scholar
• Hohl M, Wagner M, Reil JC, et al. HDAC4 controls histone methylation in response to elevated cardiac load[J]. J Clin Invest. 2013;123(3):1359–1370.
   PubMed Web of Science ®Google Scholar
• Rojo De La Vega M, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer[J]. Cancer Cell. 2018;34(1):21–43.
   PubMed Web of Science ®Google Scholar
• Cuadrado A, Rojo AI, Wells G, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases[J]. Nat Rev Drug Discov. 2019;18(4):295–317.
   PubMed Web of Science ®Google Scholar
• Nie P, Meng F, Zhang J, et al. Astragaloside IV exerts a myocardial protective effect against cardiac hypertrophy in rats, partially via activating the Nrf2/HO-1 signaling pathway[J]. Oxid Med Cell Longev. 2019;2019:4625912.
   PubMed Web of Science ®Google Scholar
• Velusamy P, Mohan T, Ravi DB, et al. Targeting the Nrf2/ARE signalling pathway to mitigate isoproterenol-induced cardiac hypertrophy: plausible role of hesperetin in redox homeostasis[J]. Oxid Med Cell Longev. 2020;2020:1–13.
   Web of Science ®Google Scholar